Shandong Xinhua Pharmaceutical Company Limited (SEHK: 719)
Health Care · Pharmaceuticals · CN
HK$5.85
-2.99% today · -25.3% 1Y
Shandong Xinhua Pharmaceutical Company Limited (SEHK: 719) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.16B.
Over the last twelve months the share price has lost 25.3%, trading between 5.18 and 8.18.
Tweenvest scores Shandong Xinhua Pharmaceutical Company Limited across four factors: quality 79/100, value 65/100, growth 52/100, dividend 90/100. Its strongest factor is dividend.
719 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.16B
- Revenue (TTM)
- $1.27B
- P/E
- 13.33
- EPS
- 0.39
- Dividend yield
- 2.90%
- Beta (5Y)
- -0.02
- 52-week high
- HK$8.18
- 52-week low
- HK$5.18
- Avg volume (3M)
- —
- Shares outstanding
- 696.68M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.